Measured dust mite and mould clean-out of bedrooms for allergy households
TL;DR Mitelow cleans and fits out the bedroom of someone with dust mite allergy, then tests whether the allergen load actually fell. Allergists refer patients, and families pay for a first visit plus quarterly follow-ups. It sells a measured, cleaner bedroom, not relief from symptoms.
Allergic rhinitis is common in Indian clinics. In a 2025 study of 40,001 patients with nasal symptoms across 19 states and union territories, 53.7% scored as having allergic rhinitis, yet only 31.5% of them had ever had an allergy test[1].
Dust mites keep turning up as the main trigger. In Indore, the mite species D. farinae was the top aeroallergen across 2,097 patients over two decades, at 47.97%[2], and a Kolkata study found the same pattern among people with nose and chest allergies[3].
Families are told to "avoid dust". Good luck with that in a humid Indian bedroom with cotton mattresses and heavy curtains, because it's close to impossible without help.
What it does, in regulatory terms: home hygiene service only. Mitelow does not diagnose, treat or claim to reduce symptoms. Treatment stays with the allergist.
A two-person crew visits the bedroom of the allergic family member. They take a dust sample from the mattress and floor for a mite-allergen test, then fit zip-on encasings to the mattress and pillows, hot-wash or replace bedding, vacuum soft furnishings with a sealed HEPA machine, and check humidity and visible mould. They use no pesticide sprays. A second sample a month later shows whether the allergen load dropped, and the family gets both results. Quarterly visits repeat the deep clean and sampling.
The seed promised "scientifically backed" allergy relief, and that had to go. A Cochrane review of 54 trials with 3,002 people found that mite control methods "cannot be recommended" for asthma[4]. Do read the review yourself, but it means Mitelow sells a measured, cleaner bedroom next to medical care, and never a cure.
The user is often a child or adult with diagnosed allergy. The payer is the household, and my estimate is ₹6,000–10,000 for the first visit including encasings, then ₹2,500–4,000 per quarterly visit. Allergists and ENT clinics refer patients and may earn nothing. What they get is a patient who can finally follow advice they already give.
The September 2025 multi-state study gave the first large Indian picture of how many people with nasal symptoms have allergy and how few have been tested[1]. Every new diagnosis comes with home advice that someone has to carry out. Professional home cleaning has also become a normal paid service, with home-services platforms selling intense cleaning by the visit[5].
There's no public figure for spending on allergen control services in India. The narrowest figure that holds up is clinical - in-clinic allergic rhinitis was 53.7% of patients with nasal symptoms in the 2025 study, which is not a population prevalence[1]. As an adjacent figure, the same paper cites 9.8% of adults in an earlier community study. Treat both as context.
Home-services platforms and local firms sell deep cleaning, but with no allergen focus and no measurement[5]. Mattress encasings can be bought online, but fitting, washing routines and follow-up are left to the family. Smogward, elsewhere in this directory, handles indoor PM2.5, which is a different problem.
There's no Indian service that measures mite allergen before and after a clean, as far as this research found.
| Difficulty | Moderate (40/100) |
| Starting capital | ₹45–80 L |
| Time to launch | 4–6 months |
The service itself is simple. The hard parts are getting allergists to refer, keeping crews consistent enough that the before-and-after numbers are reliable, and holding the line on claims when parents badly want to hear that their child will stop sneezing.
Mitelow is a hygiene service, so no health licence applies as long as it never claims to treat anyone.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI give any medical advice or read results as a diagnosis. Mitelow measures dust, and the allergist treats the patient.
Want to work out the AI layer for Mitelow? Talk to Yash →
I think a founder with a clinic network or a cleaning business could test this cheaply. If you need a big market quickly then avoid it. Prove first that measured allergen load falls by half after the first visit in at least 70% of homes, and that 40% of families book a second visit.
Plan for about ₹45–80 L, mostly for crews, sealed HEPA machines, encasing stock and lab tests.
No health licence, as long as you make no treatment claims and use no pesticide sprays. You still need company registration, GST and DPDP compliance.
Yes. Check local advertising rules on health claims, pesticide rules and data protection before you launch.
The free Mitelow validation kit has the line-by-line capital breakdown, the effort scoring, the claims and data-protection checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for families and allergists, and 5 assumptions to test. Download the kit →
Thinking about building Mitelow or something close to it? The make-or-break work is earning allergist referrals while keeping every claim inside what the evidence supports, which is a balancing act I'm happy to think through with you. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.